Labcorp EBITDA 2010-2024 | LH

Labcorp EBITDA for the quarter ending December 31, 2024 was $0.385B, a 4478.57% increase year-over-year.

  • Labcorp 2024 EBITDA was 1.73B, a 32.8% increase from 2023.
  • Labcorp 2023 EBITDA was 1.303B, a 33.99% decline from 2022.
  • Labcorp 2022 EBITDA was 1.974B, a 45.56% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Labcorp EBITDA 2010-2024 | LH

  • Labcorp 2024 EBITDA was 1.73B, a 32.8% increase from 2023.
  • Labcorp 2023 EBITDA was 1.303B, a 33.99% decline from 2022.
  • Labcorp 2022 EBITDA was 1.974B, a 45.56% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.5B
Becton Dickinson (BDX)$65.3B
Cardinal Health (CAH)$30.6B
Straumann Holding AG (SAUHY)$23.7B
Cooper (COO)$17.3B
Align Technology (ALGN)$15.1B
West Pharmaceutical Services (WST)$14.6B
Henry Schein (HSIC)$9.7B
Merit Medical Systems (MMSI)$6.2B
DENTSPLY SIRONA (XRAY)$3.8B
Patterson (PDCO)$2.7B
CONMED (CNMD)$1.9B
STAAR Surgical (STAA)$876M
Lifevantage (LFVN)$230M
Pro-Dex (PDEX)$112M